ITGAX and obesity disorder: Specifically, EK therapy reduced the number of pro-inflammatory CD11c+ macrophages (M1 macrophages) and altered the balance between pro-inflammatory Ly6chi monocytes and anti-inflammatory Ly6clow monocytes, suggesting a modulation of inflammatory responses associated with obesity.